Metraipolis › archive › dc_da73a4ae5653

CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial — Europe PMC PMID:41322200

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41322200
DOI
10.1016/j.omton.2025.201081
License (as archived)
solo-consultazione
Archived
2026-11-08T20:57:04.474Z
SHA-256 of the archived text
ca7b92cd50693c345973e18b3f8781a30ef0059d1bef0ff042a2af70bc42d35d
Stable URL of this page
https://metraipolis.com/documento/dc_da73a4ae5653

How to cite

CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial — Europe PMC PMID:41322200 — Europe PMC (en), https://europepmc.org/article/MED/41322200 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da73a4ae5653 (Metraipolis archive dc_da73a4ae5653, sha256 ca7b92cd50693c345973e18b3f8781a30ef0059d1bef0ff042a2af70bc42d35d)
BibTeX
@misc{dcda73a4ae5653,
  title = {CD19 CAR T cell therapy BY19 for pediatric and adult patients with relapsed or refractory B cell neoplasms in Belarus: Phase 1 trial — Europe PMC PMID:41322200},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41322200},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da73a4ae5653; sha256 ca7b92cd50693c345973e18b3f8781a30ef0059d1bef0ff042a2af70bc42d35d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41322200. Agents can read the archived copy with the MCP tool read_document.